June 5, 2008 — A case study concerning the Axiom Worldwide’s DRX9000, published in the 2008 issue of the European Musculoskeletal Review, was mentioned in an online newsletter from the Food and Drug Administration (FDA).
The FDA news item was headlined, “Axiom Case Study Yields Favorable Findings with Back Pain Device.”
It read, in part, “A study evaluating Axiom Worldwide’s DRX9000 true nonsurgical spinal decompression system has produced positive results. … The study chronicled a patient who underwent 22 treatments with the device over a seven-week period and reported significant pain relief at the end of the study.”
Source: Axiom WorldWide, www.axiomworldwide.com
Related Posts
Profile: Chiropractic office thrives, offers advice for COVID-19 business continuity- The nose knows: Nutritional supplements for sinusitis
- Green tea reduced Inflammation, may inhibit prostate cancer tumor growth
- ChiroTouch named among fastest growing companies in America
- Dennis Sparkman of Progressive Laboratories receives ASQ-Certified Six Sigma Green Belt
